I was diagnosed with relapsing-remitting multiple sclerosis (RRMS) at the age of 46.

Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Following treatment with TG Therapeutics’ Briumvi, patients reported improvements in satisfaction and quality of life.

Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.

An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a low ...

While there's currently no cure for multiple sclerosis, a lot of new treatment options have become available—many in just the last few years. There are pills and capsules taken daily or even a few ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...

BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday morning — making the step forward toward finding a cure for multiple ...

HOUSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project ...